BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IAS-USA//NONSGML PDA Calendar Version 1.0//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:ee79b7192cbb5bb1eb4148ebd5f360c0
ORGANIZER:registration@iasusa.org
DTSTAMP:20261026T000228Z
LOCATION:
SUMMARY:Cirrhosis in 2018: New Help for an Old Liver
DESCRIPTION:Overview\n\nAssessment of Needs\nThe IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians.\nLearning Objectives\nUpon completion of this webinar\, learners will be able to:\n\n 	Use current diagnostic techniques to reliably diagnose cirrhosis in patients with chronic liver injury\n 	Identify the appropriate use of antibiotics in cirrhosis and describe how the gut microbiome may influence the natural history of cirrhosis\n 	Describe what happens to the liver after successful treatment of hepatitis C or hepatitis B and identify who remains at risk for complications\n\nRegistration\nWho Should Attend\nThis advanced webinar is designed for clinical decision makers who are actively involved in HCV care and research.\n\nThis activity is also relevant for registered nurses\, PharmDs\, and other health professionals.\n\nIndividual registration is required\, even if you are viewing as a group\, in order to receive CME credit or a certificate of participation.\n\nRegistration closes on Monday\, February 26\, 2018\, 4:00 PM (PT).\n\nCertificates will be available after the completion of the evaluation and claim form.\n\nFor more information or questions\, please contact the registration department at registration@iasusa.org or 415-544-9400.\nConflicts of Interest\nIn the interest of maintaining the independence of its CME activities\, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME)\, the IAS–USA requires all persons with control of content (eg\, faculty\, IAS–USA Board members\, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.\n\n\n\n\nContinuing Education Credits\n\nCME Credits\nThe International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.\n\nThe IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.\nNursing Credits\nEducational Review Systems is an approved approver of continuing nursing education by the Alabama State Nursing Association\, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115.  This program is approved for 1.25 hours of continuing nursing education.\n\nEducational Review Systems is also approved for nursing continuing education by the state of California\, the state of Florida and the District of Columbia.\n\nThis program contains 1.25 hours of pharmacotherapy credit.\nPharmacy Credits\nEducational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 1.25 hours (0.125 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.\nUAN  # 0761-9999-18-021-L01-P\n\n\n\n\nGrant Support\n\n\nThis activity is part of the IAS–USA national educational effort that is funded\, in part\, by charitable contributions from commercial companies. Per IAS–USA policy\, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity\, including its content\, development\, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.\n\nPLATINUM SUPPORTER\nGilead Sciences\, Inc\n\nBRONZE SUPPORTER\nAbbVie\n\nADDITIONAL SUPPORT\nMerck\nFrequently Asked Questions\nView our list of FAQs about attending a webinar.\n\nFurther Questions?\nPlease contact the registration department at registration@iasusa.org or 415-544-9400.
STATUS:CONFIRMED
CATEGORIES:Webinars
URL;VALUE=URI:https://www.iasusa.org/events/webinar-2018-monto/
DTSTART:20180227T180000Z
DTEND:20180227T191500Z
END:VEVENT
END:VCALENDAR